NPAF Urges Government Officials to Preserve Access to ESAs for Cancer Patients |
|
NPAF and its Scientific Advisory Board, representing millions of cancer and other chronically ill patients, have joined the chorus of leading physicians and researchers in the field of hematology and oncology in urging the Centers for Medicare and Medicaid Services (CMS) to maintain full patient access to Erythropoiesis Stimulating Agents (ESAs). |
| < Prev | Next > |
|---|
News & Events